MARKET REPORT: Astrazeneca’s game-changer jab given rubber stamp
Drugs giant Astrazeneca reached a crucial milestone yesterday after regulators approved its Covid vaccine for use in the UK. The second-largest company on the FTSE 100 has spent months developing the jab with Oxford University. Around 530,000 doses will be available from next week, turbocharging the number of vaccines that can be rolled out in … Read more